Last reviewed · How we verify
NCT04815369
Evaluating UTI Diagnosis in Nursing Homes
trial in Urinary Tract Infections. Withdrawn.
30 May 2024
Quick facts
| Lead sponsor | Pathnostics |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 7 June 2021 |
| Primary completion | 30 May 2024 |
| Estimated completion | 8 November 2024 |
| Sites | 1 location across United States |
Conditions studied
- Urinary Tract Infections — all drugs for Urinary Tract Infections →
Sponsor
Pathnostics
Who can join
65 and older, any sex, with Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective, multicenter, comparative cohort observational study is to determine whether the use of Guidance® UTI Clinical Pathway, a standardized infrastructure for specimen collection and result delivery, compared with current traditional pathways for urine testing reduces the proportion of UTI patients with poor outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04815369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Tract Infections
Currently open trials in the same condition.
- NCT06976125 — Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulat · NA · recruiting
- NCT06808451 — Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture · NA · recruiting
- NCT07186465 — Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis · Phase 4 · recruiting
- NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
- NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
Other Pathnostics trials
Trials by the same sponsor.
- NCT05385536 — Evaluating UTI Outcomes in at Risk Populations · completed
- NCT05091931 — Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting · completed
- NCT04815018 — Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2 · terminated
- NCT04817865 — Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection · withdrawn
- NCT03931538 — Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04815369 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pathnostics
- Last refreshed: 28 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04815369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing